Medicare Enrolled
Dr. Mahjabeen Haq, D.O.
Rheumatology · Babylon, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Haq from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Haq?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Haq
Dr. Mahjabeen Haq is a rheumatology specialist in Babylon, NY, with 13 years of NPI registration. Based on federal Medicare data, Dr. Haq performed 27,876 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Haq received a total of $16,265 from 39 pharmaceutical and/or device companies across 733 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Haq is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years of NPI registration
▲ Top 11% volume in NY
$16,265 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗27,876
Medicare services
Top 11% in NY for rheumatology
Not available
Unique patients (not deduplicated)
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 13,920 | $19 | $55 |
| Romosozumab injection (Evenity) for osteoporosis | 11,970 | $8 | $14 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
741 | $111 | $300 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
347 | $13 | $60 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
224 | $77 | $200 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
148 | $1 | $8 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
132 | $145 | $400 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
128 | $46 | $350 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
59 | $95 | $450 |
| Bone density scan (DEXA) of hip, pelvis, and spine This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures. |
33 | $62 | $350 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
27 | $1 | $15 |
| 5% dextrose/water (500 ml = 1 unit) | 27 | $1 | $15 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
25 | $61 | $175 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
20 | $72 | $80 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
20 | $36 | $40 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
19 | $122 | $400 |
| Tendon or ligament injection A procedure involving the injection of medication into a tendon or ligament. |
18 | $56 | $200 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
18 | $55 | $400 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.3% high complexity
95.0% medium
4.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,265
Total received (2018-2024)
Avg $2,324/year across 7 years
Top 20% in NY for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
733
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,346
2023
$5,321
2022
$3,092
2021
$2,022
2020
$408
2019
$1,890
2018
$187
Payments by company (2024)
Amgen Inc.
$724
Janssen Biotech, Inc.
$476
UCB, Inc.
$441
ABBVIE INC.
$374
Lilly USA, LLC
$258
AstraZeneca Pharmaceuticals LP
$170
ANI Pharmaceuticals, Inc.
$168
Boehringer Ingelheim Pharmaceuticals, Inc.
$167
Novartis Pharmaceuticals Corporation
$140
GlaxoSmithKline, LLC.
$96
Radius Health, Inc.
$73
PFIZER INC.
$64
Kiniksa Pharmaceuticals International, plc
$54
Ferring Pharmaceuticals Inc.
$44
Mallinckrodt Hospital Products Inc.
$31
Fresenius Kabi USA, LLC
$29
Teva Pharmaceuticals USA, Inc.
$20
Aurinia Pharma U.S., Inc.
$17
Top 3 companies account for 49.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,780
AstraZeneca Pharmaceuticals LP
$1,810
Janssen Biotech, Inc.
$1,610
ABBVIE INC.
$1,405
Horizon Therapeutics plc
$1,161
UCB, Inc.
$1,094
Lilly USA, LLC
$931
PFIZER INC.
$604
Boehringer Ingelheim Pharmaceuticals, Inc.
$524
GlaxoSmithKline, LLC.
$439
Novartis Pharmaceuticals Corporation
$422
Mallinckrodt Hospital Products Inc.
$380
Regeneron Healthcare Solutions, Inc.
$358
AbbVie Inc.
$320
AbbVie, Inc.
$285
Genentech USA, Inc.
$276
Radius Health, Inc.
$269
ANI Pharmaceuticals, Inc.
$193
Ferring Pharmaceuticals Inc.
$168
Merck Sharp & Dohme Corporation
$162
E.R. Squibb & Sons, L.L.C.
$160
Horizon Pharma plc
$123
Aurinia Pharma U.S., Inc.
$123
Fresenius Kabi USA, LLC
$107
Alexion Pharmaceuticals, Inc.
$79
GENZYME CORPORATION
$63
Hikma Pharmaceuticals USA
$54
Kiniksa Pharmaceuticals International, plc
$54
Exeltis, USA Inc.
$45
Biohaven Pharmaceutical Holding Company Ltd.
$45
Zimmer Biomet Holdings, Inc.
$42
Pacira Pharmaceuticals Incorporated
$31
Kowa Pharmaceuticals America, Inc.
$29
MEDEXUS PHARMA, INC.
$29
Celgene Corporation
$22
Amarin Pharma Inc.
$20
Teva Pharmaceuticals USA, Inc.
$20
Ultragenyx Pharmaceutical Inc.
$17
Shire North American Group Inc
$13
Top 3 companies account for 38.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · AccuFill · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CRYSViTA · CYLTEZO · Cimzia · EUFLEXXA · EVENITY · Enbrel · HUMIRA · Humira · IDACIO · INFLECTRA · Iovera · JANUVIA · JARDIANCE · KEVZARA · KRYSTEXXA · LUPKYNIS · Livalo · Mitigare · NURTEC ODT · OFEV · OMVOH · ORENCIA · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SEGLENTIS · SIMPONI ARIA · SKYRIZI · STRENSIQ · TALTZ · TAVNEOS · TREMFYA · Tavneos · Truxima · Tymlos · Vascepa · XELJANZ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
94
County median income
$128,329
Nearest hospital to ZIP centroid (approximate)
BRUNSWICK HOSPITAL CENTER, INC.
3.6 mi
3.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Haq is a mixed practice specialist, with above-average Medicare volume (top 11% in NY).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Haq experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Haq performed 13,920 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Haq receive payments from pharmaceutical companies?
Yes. Dr. Haq received a total of $16,265 from 39 companies across 733 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Haq's costs compare to other rheumatologists in Babylon?
Dr. Haq's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Haq) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Babylon
Browse rheumatologists in Babylon ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in NY
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in NY
Which NY rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology